Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01273597 · BASELINE

Baseline characteristics

Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands · Source last updated 2013-01-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      60
    units
    Participants
groups
  1. description
    Participants with chronic kidney disease (CKD) stage 5 receiving haemodialysis with a diagnosis of secondary hyperparathyroidism (SHPT)
    id
    BG000
    title
    End-stage Kidney Disease With Secondary Hyperparathyroidism
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          31
          upper Limit
          86
          value
          57.7
    dispersion Type
    FULL_RANGE
    param Type
    MEAN
    title
    Age Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          31
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          29
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          60
      title
      Hungary
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      60
    units
    Participants
groups
  1. description
    Participants with chronic kidney disease (CKD) stage 5 receiving haemodialysis with a diagnosis of secondary hyperparathyroidism (SHPT)
    id
    BG000
    title
    End-stage Kidney Disease With Secondary Hyperparathyroidism
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          31
          upper Limit
          86
          value
          57.7
    dispersion Type
    FULL_RANGE
    param Type
    MEAN
    title
    Age Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          31
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          29
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          60
      title
      Hungary
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice